PHILIPS每日一例:颅内结核误诊为颅内转移性恶性肿瘤一例

2022-09-07 放射沙龙 临床误诊误治

对于颅内结核,临床医生应认真仔细询问患者病史和细致查体,并及时行脑脊液检查和结核分枝杆菌DNA检测,以避免误诊的发生。

1 病例资料

女,25岁。因低热、腹痛3个月,右侧肢体无力、言语不清1个月入院。3个月前因受凉后出现咳嗽、低热,未予诊治,症状无缓解,半个月后就诊于当地某诊所,予静脉注射(具体药物不详)3 d后仍反复低热,并出现右下腹痛、便秘。

入院40 d 前静脉输液过程中突发言语不能,右侧肢体无力伴活动障碍,转诊市级某医院,查脑脊液常规、生化检查无明显异常,诊断:①脑梗死;②颅内感染?③肺多发小结节影,转移瘤?④肠肿瘤?给予抗血小板聚集、抗感染等治疗,症状无好转,右侧肢体无力逐渐加重。

入院半个月前就诊厦门某医院,胸部CT示双肺多发性转移瘤。肠镜示回肠末段及回盲部溃疡,考虑:①克罗恩病?②肠结核及肠肿瘤待排。病理示小肠及结肠黏膜慢性炎,急性活动期,另见炎性坏死组织。

正电子发射计算机断层显像(PET)-CT示右半结肠癌并腹腔、腹膜后多发淋巴结转移,双肺转移,脑转移。

诊断:右半结肠癌伴双肺转移、脑转移。经相应治疗后右侧偏瘫无好转。入我科10 d前就诊于我院消化科,头颅CT检查示:脑膜炎,结核可能。胸、腹部CT检查示:小肠、升结肠多节段管壁增厚,肠系膜淋巴结增大,双肺多发病灶,考虑结核,见图1。遂转入我科。

图1 颅内结核抗结核治疗前胸部CT所示双肺多发病灶,结核可能

查体:表情呆滞,言语不清,颈强直;双肺呼吸音粗;右侧肢体肌力I级、肌张力升高,克氏征阳性,右侧Babinski征阳性。查脑脊液:结核杆菌DNA测定1640,李凡他试验(+ +),葡萄糖0.84 mmol/L,总蛋白1.53 g/L,氯化物113.9 mmol/L,白细胞105×106 /L,提示结核性脑膜炎。查红细胞沉降率(血沉)70.0 mm/h。

诊断:①结核性脑膜炎;②肺结核;③肠结核。

予大剂量异烟肼、利福霉素、链霉素、吡嗪酰胺及腰椎穿刺鞘内注射异烟肼抗结核治疗,辅以降颅内压治疗。

1周后症状好转,无低热、盗汗。复查脑脊液:李凡他试验( + ) ,葡萄糖2.39 mmol/L,总蛋白0.51 g/L,氯化物121 mmol/L,白细胞80.50×106 /L;查血沉30 mm/h,提示病情好转。后院外继续规范抗结核治疗。

2个月后复查脑脊液恢复正常,胸部CT检查示病灶明显吸收,见图2。目前仍在随访期,患者言语清晰、对答切题,右侧肢体肌力Ⅴ级,肌张力正常。

图2 颅内结核抗结核治疗2 个月后复查胸部CT所示病灶明显吸收

2 讨论

颅内结核为结核杆菌经血行播散至颅内形成的多形性病变,其并发症严重、病死率高,是结核病危害最严重的类型之一。肺外结核因发病隐匿、常形成肿块、症状不典型或变化多样,易与肿瘤混淆,因此常导致误诊发生。

2.1 与颅内肿瘤的鉴别

颅内结核临床表现缺乏特征性,与病灶累及部位有关,主要表现为头痛、头晕、呕吐、抽搐、意识障碍、偏瘫等,故临床上易误诊。颅内结核脑脊液外观常表现为轻度磨玻璃样,蛋白含量升高,葡萄糖及氯化物含量降低,白细胞数升高,腺苷脱氨酶(ADA)明显升高。但颅内肿瘤脑脊液检查也可表现为蛋白含量升高,葡萄糖及氯化物含量降低,但脑脊液外观多透明,白细胞数一般不升高,ADA升高不如结核明显。结合血沉、头颅CT增强扫描及磁共振成像(MRI)、结核菌素纯蛋白衍生物试验、结核抗体、结核DNA检测等检查有助于两者的鉴别。

2.2 误诊原因

①临床表现无特异性,与相应肿瘤表现相似。本例肠结核表现为右下腹痛、便秘,结核性脑膜炎表现为右侧肢体偏瘫、言语不清,与颅内恶性肿瘤表现类似。②过于依赖PET-CT 检查结果。③本例结核的全身毒性症状不明显,仅表现为低热,故使临床医生忽略了结核病的诊断。

2. 3 防范误治措施

①提高警惕性,认真仔细询问患者病史和细致查体,对有肺结核病史的患者应想到肺外结核可能,对无肺结核病史者也不要轻易排除肺外结核。②应及时完善结核分枝杆菌DNA检测。该技术快速准确、特异性高、假阴性率低、耗时短,缩短了肺外结核诊断的检测时间,为早期诊断、治疗提供了有效支持。③对诊断困难,特别是与相应部位肿瘤鉴别困难者应及时取活组织行病理学检查。④怀疑颅内结核时可多次反复行腰椎穿刺脑脊液检验,对其确诊极为重要。⑤通过现有方法不能确诊且又高度怀疑颅内结核者,可行规范诊断性抗结核治疗,定期随访,以正确评价抗结核治疗效果。

总之,对于颅内结核,临床医生应认真仔细询问患者病史和细致查体,并及时行脑脊液检查和结核分枝杆菌DNA检测,以避免误诊的发生。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1247719, encodeId=e6bd124e719d0, content=很好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCcPZxo8VtmYhf6icgcOqlZ3zmVPOUCGfwY285BTLw6UJpM6yvRERz9m4icc8icSPaNCzGl6ZLlHibyJ8lIrsiccISw/132, createdBy=ee961608717, createdName=xiaofushi, createdTime=Wed Sep 07 17:26:22 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254455, encodeId=f06e125445562, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377815, encodeId=a90513e781561, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387026, encodeId=08c3138e0263a, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2022-09-07 xiaofushi

    很好,学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1247719, encodeId=e6bd124e719d0, content=很好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCcPZxo8VtmYhf6icgcOqlZ3zmVPOUCGfwY285BTLw6UJpM6yvRERz9m4icc8icSPaNCzGl6ZLlHibyJ8lIrsiccISw/132, createdBy=ee961608717, createdName=xiaofushi, createdTime=Wed Sep 07 17:26:22 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254455, encodeId=f06e125445562, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377815, encodeId=a90513e781561, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387026, encodeId=08c3138e0263a, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1247719, encodeId=e6bd124e719d0, content=很好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCcPZxo8VtmYhf6icgcOqlZ3zmVPOUCGfwY285BTLw6UJpM6yvRERz9m4icc8icSPaNCzGl6ZLlHibyJ8lIrsiccISw/132, createdBy=ee961608717, createdName=xiaofushi, createdTime=Wed Sep 07 17:26:22 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254455, encodeId=f06e125445562, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377815, encodeId=a90513e781561, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387026, encodeId=08c3138e0263a, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2021-11-10 仁者大医
  4. [GetPortalCommentsPageByObjectIdResponse(id=1247719, encodeId=e6bd124e719d0, content=很好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCcPZxo8VtmYhf6icgcOqlZ3zmVPOUCGfwY285BTLw6UJpM6yvRERz9m4icc8icSPaNCzGl6ZLlHibyJ8lIrsiccISw/132, createdBy=ee961608717, createdName=xiaofushi, createdTime=Wed Sep 07 17:26:22 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254455, encodeId=f06e125445562, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377815, encodeId=a90513e781561, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387026, encodeId=08c3138e0263a, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Nov 10 01:01:21 CST 2021, time=2021-11-10, status=1, ipAttribution=)]

相关资讯

这个部位DWI高信号,不要以为是脑梗死!

如病人出现脑桥-小脑损害的症状和体征,MRI表现为脑桥旁正中梗死以及双侧对称性小脑中脚异常信号,应想到脑桥小脑纤维WD可能,以避免误诊。

免费试听!江神-脑梗死概念及检查手段

他来了!江湖人称“江神”的影像科大咖,带着他28年的经验来了!

医学图文:图说脑梗死的主要影像诊断

脑梗死的发病机制和临床表现及分类。

Neurology:多吃鱼有益心脑血管健康

鱼类是长链-3多不饱和脂肪酸(LC n-3 PUFA)的主要来源,食用鱼类可能有助于降低与年龄有关的脑疾病的风险。多吃鱼,或血液中n-3多不饱和脂肪酸的含量增加,与较低的认知能力下降、中风和痴呆的风险